Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axis

Department of Cellular and Molecular Medicine, The University of Arizona, Tucson, ArizAsthma and Airway Disease Research Center, The University of Arizona, Tucson, ArizBIO5 Institute, The University of Arizona, Tucson, ArizArizona Center for the Biology of Complex Diseases, The University of Arizona, Tucson, Ariz

Source link

Products You May Like

Articles You May Like

COVID-19 Vaccines for Children and Teens
Pfizer-BioNTech COVID-19 Vaccine Overview and Safety
THCB Gang Episode 72, Nov 18 1pm PT – 4pm ET – The Health Care Blog
Start your coverage. See how to pay your monthly premium directly to your health insurance company
Housing and asthma disparities – Journal of Allergy and Clinical Immunology

Leave a Reply

Your email address will not be published. Required fields are marked *